EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effectiveness and Safety of Oral Compound Glycyrrhizin Followed by Phototherapy for the Treatment of Progressive Vitiligo in Children

Li Zhang iD, Jian Zhang, Suqing Liu, Zhengzhou Shi, Yijian Zhu iD, Min Jiang, Leihong Xiang iD

Pigment Cell & Melanoma Research · 2025

DOI: 10.1111/pcmr.13226 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pigment Cell & Melanoma Research, 2025. Verfasst von Li Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Vitiligo, Glycyrrhizic Acid, Phototherapy, Disease Progression. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Medical Innovation Research Special Project of Science and Technology Commission of Shanghai Municipality, The National Natural Science Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Childhood vitiligo, distinct from its adult counterpart, presents unique treatment challenges. Glycyrrhizin inhibits the release of high‐mobility group box 1 (HMGB1) protein from keratinocytes, preventing melanocyte apoptosis and autophagy. Furthermore, the orally administered compound glycyrrhizin (OCG) effectively treats various autoimmune disorders, demonstrating long‐term efficacy, safety, and tolerability. This study compared the efficacy of OCG and oral prednisone (OP), followed by phototherapy, in patients with progressive childhood vitiligo at 52 weeks' follow‐up. Fifty children with vitiligo were randomized into two groups according to treatment: OCG (50–150 mg/day) followed by phototherapy ( n = 25) and OP (5–10 mg/day) followed by phototherapy ( n = 25). At Week 24, a halt in disease progression (HDP) was observed in 20 (80%) patients in the OCG group and 21 (84%) in the OP group, with no significant difference ( p > 0.99) . However, the mean time to achieve HDP was significantly shorter in the OP group than in the OCG group (14.73 ± 4.84 vs. 19.13 ± 4.82 weeks; p < 0.01). In addition, serum HMGB1 concentrations were significantly reduced after treatment with OCG at Week 24 (3.02 ± 0.83 vs. 0.95 ± 0.36 ng/mL [ p < 0.01]; OP, 2.79 ± 0.16 vs. 1.03 ± 0.34 ng/mL [ p < 0.01]). The decline in Vitiligo Area Scoring Index (VASI) score at the end of follow‐up (i.e., Week 52) did not show a statistically significant difference between the OCG and OP groups (52.31% ± 14.86% vs. 55.71% ± 21.23%; p = 0.55). The therapeutic response of the clinical markers of progression was good and comparable between the OCG and OP groups. OCG demonstrated similar efficacy to OP followed by phototherapy in controlling disease activity and promoting repigmentation in children with vitiligo at 52 weeks of follow‐up. Trial Registration: ChiCTR2400086844

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoGlycyrrhizic AcidPhototherapyDisease ProgressionHumansChildFemaleMaleTreatment OutcomeAdministration, OralAdolescentChild, PreschoolHMGB1 ProteinPrednisone

Stichwörter der Autor:innen

childhood vitiligocompound glycyrrhizinrepigmentation

Substanzen

Glycyrrhizic AcidHMGB1 ProteinPrednisone

Autor:innen und Institutionen

  • Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.

ORCID-Profile: Li Zhang, Yijian Zhu, Leihong Xiang

Förderung

  • Medical Innovation Research Special Project of Science and Technology Commission of Shanghai Municipality
  • The National Natural Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, L., Zhang, J., Liu, S., Shi, Z., Zhu, Y., Jiang, M., & Xiang, L. (2025). Effectiveness and Safety of Oral Compound Glycyrrhizin Followed by Phototherapy for the Treatment of Progressive Vitiligo in Children. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.13226

Vancouver

Zhang L, Zhang J, Liu S, Shi Z, Zhu Y, Jiang M, et al. Effectiveness and Safety of Oral Compound Glycyrrhizin Followed by Phototherapy for the Treatment of Progressive Vitiligo in Children. Pigment Cell & Melanoma Research. 2025. doi:10.1111/pcmr.13226

BibTeX
@article{Zhang2025,
  author = {Zhang, Li and Zhang, Jian and Liu, Suqing and Shi, Zhengzhou and Zhu, Yijian and Jiang, Min and Xiang, Leihong},
  title = {Effectiveness and Safety of Oral Compound Glycyrrhizin Followed by Phototherapy for the Treatment of Progressive Vitiligo in Children},
  journal = {Pigment Cell & Melanoma Research},
  year = {2025},
  doi = {10.1111/pcmr.13226}
}
Kostenlos starten →